GlassScriptPhysician profile
Ayhan Yoruk
NPI 1003235052
$118,128.02
in general payments reported to CMS, 2019-2025
28 companies · $29K in 2025
The $29K reported for 2025 was more than what 92% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,233 · 2020: $22K · 2021: $3,431 · 2022: $22K · 2023: $18K · 2024: $16K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35K · Travel and Lodging: $20K · Consulting Fee: $7,922 · Education: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35,104.15 |
| Travel and Lodging | $20,168.65 |
| Consulting Fee | $7,922.41 |
| Education | $427.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $25,569.38 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Medtronic, INC. | $25,316.90 | 2021-2025 | Micra, Affera Mapping System, Linq II |
| Boston Scientific Corporation | $23,962.25 | 2019-2025 | Farapulse, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $21,848.18 | 2021-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Abbott Laboratories | $10,122.77 | 2019-2025 | Ensite, Aveir, Gallant |
| Medical Device Business Services, INC. | $3,031.57 | 2022-2024 | Carto 3 |
| Atricure, INC. | $2,616.36 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Impulse Dynamics (USA) INC. | $1,336.36 | 2024-2025 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $744.83 | 2020-2025 | Lifevest |
| Baylis Medical Company INC | $721.59 | 2021 | |
| Cardiva Medical, INC. | $575.36 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $517.28 | 2019-2020 | |
| Abiomed | $392.21 | 2023-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $187.97 | 2022-2024 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $171.63 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $163.25 | 2022-2025 | |
| Pfizer INC. | $129.60 | 2020 | |
| Cardiofocus, INC. | $126.85 | 2023 | Heartlight System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.13 | 2023-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $96.35 | 2023 | Farxiga |
| Amgen INC. | $91.71 | 2022-2024 | Repatha |
| Baxter Healthcare | $56.39 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Inari Medical, INC. | $54.61 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kiniksa Pharmaceuticals International, Plc | $46.55 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $43.19 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $36.80 | 2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $30.59 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $20.36 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayhan Yoruk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.